# Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts

## TL;DR

Experts in clinical mycology gathered to address challenges like antifungal resistance and climate change's impact on fungal infections.

## Contribution

The paper highlights new strategies, including host-directed therapies and AI, to improve fungal infection management.

## Key findings

- Antifungal resistance and climate change are major concerns in clinical mycology.
- Novel approaches like AI and host-directed therapies show promise in managing fungal infections.
- Collaboration among clinicians, researchers, and industry partners is crucial for progress.

## Abstract

The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve outcomes. Key themes of the 2024 biennial meeting included emergence of antifungal resistance, the effects of climate change on incidence of IFI, recent healthcare‐and community‐associated outbreaks and their management, and the potential benefits of novel approaches, such as innovative study designs, host‐directed diagnostics and therapies, and artificial intelligence in clinical and academic mycology.